Delaware House Bill 320 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 18-0)
Status: Passed on April 28 2022 - 100% progression
Action: 2022-04-28 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]

In 2000, the United States Federal Drug Administration ("FDA") first approved the Risk Evaluation and Mitigation Strategy ("REMS") for Mifeprex; and approved the generic version of Mifeprex, Mifepristone, in 2019. A regimen approved by the FDA in 2016 for Mifeprex and Mifepristone includes the use of Misoprostol. Under the REMS approved by the FDA, healthcare providers who wish to prescribe Mifepristone, Misoprostol, or Mifeprex must complete a Prescriber Agreement before ordering and dispensing the medication. Physicians assistants and advanced practiced registered nurses (APRNs) are healthcare providers who are eligible to prescribe these medications under the REMS. This bill allows physician assistants and advanced practice registered nurses to prescribe medication for the termination of pregnancy including Mifeprex, Mifepristone, and Misoprostol.

An Act To Amend Title 24 Relating To Prescribing Medications For The Termination Of Pregnancy.

Rep. Debra Heffernan [D]	Sen. Kyle Gay [D]	Sen. Bryan Townsend [D]	Sen. Sarah McBride [D]
Sen. Laura Sturgeon [D]	Rep. Valerie Longhurst [D]	Rep. Melissa Minor-Brown [D]	Rep. Sherry Dorsey Walker [D]
Sen. Stephanie Hansen [D]	Sen. David Sokola [D]	Sen. Charles Paradee [D]	Rep. Krista Griffith [D]
Rep. Kendra Johnson [D]	Rep. Paul Baumbach [D]	Rep. David Bentz [D]	Rep. John Kowalko [D]
Rep. Eric Morrison [D]	Rep. Edward Osienski [D]

2022-04-07 - Senate - Senate Third Reading (Y: 14 N: 7 NV: 0 Abs: 0) [PASS]
2022-03-24 - House - House Third Reading (Y: 25 N: 15 NV: 0 Abs: 1) [PASS]

Date	Chamber	Action
2022-04-28		Signed by Governor
2022-04-07		Passed By Senate. Votes: 14 YES 7 NO
2022-04-05		Reported Out of Committee (Legislative Oversight & Sunset) in Senate with 3 Favorable
2022-03-31		Re-Assigned to Legislative Oversight & Sunset Committee in Senate
2022-03-24		Assigned to Health & Social Services Committee in Senate
2022-03-24		Passed By House. Votes: 25 YES 15 NO 1 ABSENT
2022-03-16		Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 3 On Its Merits
2022-03-09		Introduced and Assigned to Health & Human Development Committee in House

Type	Source
Summary	https://legis.delaware.gov/BillDetail?LegislationId=79202
Text	https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=79202&legislationTypeId=1&docTypeId=2&legislationName=HB320
Roll Call	https://legis.delaware.gov/json/RollCall/GetRollCallVoteByRollCallId#52971
Roll Call	https://legis.delaware.gov/json/RollCall/GetRollCallVoteByRollCallId#53008